[MCOH-EH] [EXTERNAL] hazardous drug administration
Erika Sweet
esweet at dhs.lacounty.gov
Fri Sep 1 07:45:49 PDT 2017
Attached are our questionnaire and exam forms. Surveillance is non-mandatory. Abnormal findings are referred to primary provider.
Thanks, Erika
Erika Sweet, RN, MSN, NP, COHN-S
Director of Employee Health Services
Los Angeles County Department of Health Services
Office (310) 222.2360
FAX (310) 222.5326
From: MCOH-EH [mailto:mcoh-eh-bounces at mylist.net] On Behalf Of Morelli, Karen J
Sent: Friday, September 01, 2017 5:39 AM
To: MCOH/EH <mcoh-eh at mylist.net>
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
I, too, would love to see if anyone has a hazardous drug surveillance program in place as our system is looking at this as well.
Karen Morelli RN, BSN
Clinical Manager
WorkHealth LLC
Eastern Maine Healthcare Systems
From: MCOH-EH [mailto:mcoh-eh-bounces at mylist.net] On Behalf Of Angeli Mancuso
Sent: Thursday, August 31, 2017 4:59 PM
To: MCOH/EH
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
*********************************************************************************************************************************************
The e-mail below is from an external source. Please do not open attachments or click links from an unknown or suspicious source.
*********************************************************************************************************************************************
Hi all,
I sincerely appreciate the input and perspectives from this group. I have some follow up questions that I'm curious how others are handling:
1) For current employees, how are you getting folks into compliance with this regulation? Are you asking them to complete the questionnaire and lab work (CBC, metabolic panel, UA) now and considering this a baseline?
2) What are you doing with abnormal lab results for these current employees? Referring to their own physician? Doing follow up and more extensive testing through Occupational Medicine to determine other underlying health conditions and then referring to PCPs?
I've really appreciated the shared policies and forms from everyone! Thanks for being such a great community!
Angeli Mancuso, RN, COHN-S/CM
Manager, Employee Health & Safety | Cottage Health
P.O Box 689 | 400 W. Pueblo St | Santa Barbara, CA 93102-0689
Office: (805) 569-7866 | Fax: (805) 569-8271
a1mancus at sbch.org<mailto:a1mancus at sbch.org> | cottagehealth.org<http://secure-web.cisco.com/16pajHqdXBK09TXg05NFPY-3lu-vrVTmCyUzWcJRA2gA06TC2Dxmh09q146hD8T0W-Pw8qR8aH5lvn2tlPeXEpcE3cnYDaLp8UpmxCwAXhd7i3PKHAU1PIe9n7jsTsltULFSos57Y26844HMXLN9ihrmAB8EBVC92S6bOy57CHH0WuM3qWq5grZQcnsx2zyicTHXT745z1yBTewoFDSYzQerJPS1Swh6KcJWxw4s0-n8uAc0Xgz2zqq7zuuJadaALYos5SalUw_6uTeE9czuqVm8IF4aZnFdaT5deq1g4PofXNf73GeIzzBHIfMfBDan9w-J2xsOpGp5LwouVgJ2xigbSaDyhfkPLMpZk6kpIgI1um8J5Lc0z_qkotz4vu_EPOhxqC6mUhRj7Ycv_L0Jl9w/http%3A%2F%2Fwww.cottagehealth.org%2F>
http://secure-web.cisco.com/1zTdAHQJ3cEl1_ZXgOBgjawDQ1JEW__Ug9W-kLimBp2wTIzDuN65wKOlhBj9mG0gYW6h-Ez9B81nNDb4ifABozP7VC7PHcbRmeCU7BfU9t6kB42eaKMCRIsroeowthL4HU1WfJJ9SRSS3TwRrT2_Vp00a5Y6rZcWJUFw2H0XEgZ7ErnhSRhPKTeRjYM3WdGkcNk3Mt3aXFSXOejfha1YGbcxn9utR2e-J6qEC1m4v1mUbxu83OdLq01UxolRAufXjdsGxZmxffFqnTYa6IZRRdqfXgQGK4D6vKGinXzCho62oNlu6z_M95DHreTiopHjYweuJ464XE-a1XcEK2NgbQYiU99eUJGzbJy-64x_qdvI-4rJZslqvSzzbGClhZjzb18y-EKht9ZbrfN_H0rT8Wg/http%3A%2F%2Fwww.lifewhereyouloveit.org<http://secure-web.cisco.com/1WorFKCWaUZyk_oxaJGcIYn1SgVnjPInpROGXBMaOdXByhl-NMa0EBxxzYP5DEJm5qOqFsZ1ir-zg-1L-LJyePC3-cvZ8N7r7pifZZjiif8TFtDeo16jOkhtlkSBOSw_Mh-Xat6um9et9rTAYSJodOH14ONHn8QURBws879gDG0SmNiCTGJDb44B_dqPVZfdT1-cWCsuPT-2NzqHc57xxhgMW4rGdrqTpjzoC6VTI-40zt6eJ8fy7lfd9lju88ko33SEId4OaLVBmwWSsPsoIBG3KhU0arbYlgig04h1G9SkVJSC8EmG29OKo4_a4e8UdKqmmTPAW_GmUQNzc4y41mFyf2RMfaHJtnBPzuxzRFyYaYKfLAFnKHDJUdlBB0FNClk9IDRFaS35uVmP9feMV7g/http%3A%2F%2Fwww.lifewhereyouloveit.org%2F>
From: MCOH-EH [mailto:mcoh-eh-bounces at mylist.net] On Behalf Of Allen-Hardy, Blythe
Sent: Tuesday, August 01, 2017 3:39 PM
To: MCOH/EH
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
I'm fairly new to the organization so still learning how it is determined who's in the program. I'm assuming that a list is giving to occur health by the director of oncology nursing. I can respond back once I get further clarification.
[Description: https://secure1.mhhs.org/branding/CORPORATE_DOWNLOADS/USER_TEMPLATES/SYSTEM/email_signature/MHH_ESIGLogo.jpg]
Blythe Allen-Hardy, MD, FACOEM
Medical Director, Employee Health
Texas Medical Center
6411 Fannin, JB500
Houston, Texas, 77030
W: 713-704-2792
C: 720-840-9593
F: 713-704-6350
Blythe.allen-hardy at memorialhermann.org<mailto:Blythe.allen-hardy at memorialhermann.org>
From: MCOH-EH [mailto:mcoh-eh-bounces at mylist.net] On Behalf Of Thrasher, Terri
Sent: Tuesday, August 01, 2017 1:34 PM
To: MCOH/EH
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
How do you determine who to place in surveillance and how many employees are you running through the surveillance labs?
Terri
Kindest regards,
Terri
Terri L. Thrasher RN MSN
Sr. Director HR
Employee Health, Occupational Safety, Environmental Health, Employee Relations, Leave Management HR Compliance/Policy, Workers Compensation, 803-SAFE, Injury Management, Non CCHMC Badging, Early Education and Childcare Center
3333 Burnet Ave
Cincinnati Ohio 45229 MLC 9006
513-636-6240
From: MCOH-EH [mailto:mcoh-eh-bounces at mylist.net] On Behalf Of Allen-Hardy, Blythe
Sent: Tuesday, August 01, 2017 2:22 PM
To: 'MCOH/EH' <mcoh-eh at mylist.net<mailto:mcoh-eh at mylist.net>>
Subject: Re: [MCOH-EH] [EXTERNAL] hazardous drug administration
Cathy,
At Memorial Hermann we have a surveillance program that I am in the process of updating due to the USP 800 requirements. We have a policy in place in our hospitals on how the drugs are handled etc and it is fairly comprehensive. The medical surveillance I believe as involved checking a CBC, UA and completing an annual questionnaire. I am developing a medical surveillance guideline that will addl laboratory tests such as LFT's, BUN/Cr to the CBC w/diff and UA. Will also add a focused exam component for post exposures.
That may be overkill but I want to make sure we have a comprehensive program. Feel free to contact me for further questions.
[Description: https://secure1.mhhs.org/branding/CORPORATE_DOWNLOADS/USER_TEMPLATES/SYSTEM/email_signature/MHH_ESIGLogo.jpg]
Blythe Allen-Hardy, MD, FACOEM
Medical Director, Employee Health
Texas Medical Center
6411 Fannin, JB500
Houston, Texas, 77030
W: 713-704-2792
C: 720-840-9593
F: 713-704-6350
Blythe.allen-hardy at memorialhermann.org<mailto:Blythe.allen-hardy at memorialhermann.org>
From: MCOH-EH [mailto:mcoh-eh-bounces+blythe.allen-hardy=memorialhermann.org at mylist.net] On Behalf Of Senior, Cathy (Employee Health)
Sent: Tuesday, August 01, 2017 11:42 AM
To: 'MCOH/EH'
Subject: [EXTERNAL] [MCOH-EH] hazardous drug administration
Does anyone have a medical surveillance plan for employees who handle hazardous drugs. We are seeing more administration of these hazardous drugs between starting the intravesical therapy and the biologics that are administered. We follow the ONS guidelines for safe handling of hazardous drugs as outlined in our policy. We already have the appropriate work practice in place including proper use of PPE and education for the staff that handle these drugs. There has been a concern voiced by one of our educators that institutions such as NIOSH have recommendations for medical surveillance to make it a comprehensive prevention program that we do not have in place. Some of the drugs we administer is Carboplatin, VP-16, Taxol, Cisplatin, Cytoxan, Erbitux, 5-FU, Abraxane, Gemzar, Herceptin, Parieto and Rituxan to name a few. We also give biologics to out-patients in our short stay unit. Any help would be much appreciated. Thanks
Cathy Senior RN BSN CDE
Employee Health Director
Penn Highlands DuBois
100 Hospital Avenue
P.O. Box 447
DuBois Pa 15801
Phone 814-375-3392
Fax 814-372-2610
cesenior at phhealthcare.org<mailto:cesenior at phhealthcare.org>
http://secure-web.cisco.com/1k6m72C40A3Ol2MQmChZ6YzZ4SY0IwHWVREXYF4nmWC-kIqDajph4SqCbt1QQwlVoyP1lHPXADE2jmr9t6Zo0X0RwHcXeE92XFzxYxGkPM5phSvDmx20ilTSrpVWQHOQdRxh_3wiaXx3zB14QNFM3AIyYDbc0adFml6SBIfq1xr4IWxgnOXNhPGmeUBWfR64-8fdZzInPtapfcvbk0QL-hc7qaCcgIDxqp10vL5vfWnZn9Q--cDXeT_YI0zGe1JJTwJrxDNT9yNTyME2cAn_X-IPihkyclwX248OCHs4eBfvsTlV0JyoWiXnCddCncbqMO-h_btc-CygnVif9T0vTixkLuKtMqsOHuaZrgQeERPkeEHlSbK3Ff8R45DjpcHS31aeZgEIIj7yBcbR8UtbAvA/http%3A%2F%2Fwww.phhealthcare.org<https://secure-web.cisco.com/1vwF3cfh91VLY75nXIwmsHHJxSHh2AuixTwM19473d6PLhzFIcxHZMwZYZChpIhuDvqHaLRla5DsUtgaevwXsMLa0VGlQ-cLG3oPygBJ1316U-L0hAJebYoBqw4QH_0UI_zIV-uB9lpcW6-qnTmA-ZgMGauP9tj16GHbhz88iO8C67UCMGAkAItiAU2r5k036V3m_PaR7euMT78M5dvjgd8UU3BxXZbUvrv15o7MAi3QnIXmVORr0xdp4Do8qVLs7XLYpx26Q0PzrFQdgSu7HQJU4YzR81vsOMA1C7XhGWnzunvhTrg6nx1o2D6Vpz9BWNpmISSQ-uXSvmnysQzBAGnW64fFj3uqQGrZ_4kDrOAsrCR1Igq9QhrACPbSDwTjj3hM86KKJB-JzTkuyEqj7NQ/https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttp-3A__www.phhealthcare.org%26d%3DDwMFAg%26c%3DP0c35rBvlN7D8BNx7kSJTg%26r%3DJmg5o1TWVLt02_ZQHrHWz9cq2GUFrnmW1sIeobramoY%26m%3DLBQ9pUzug6rrSq8qu7iJ3NLRcznXWVMx57JXstYZLPw%26s%3DGnYU8mgtZmxYUko7egK2EzFHKUBA9Hy1o8PV9dCxwP0%26e%3D>
[PHH ESig Logo 150dpi]
This email and any attached files are sensitive in nature and intended solely for the intended recipient(s). If you are not the named recipient you should not read, distribute, copy or alter this email. Any views or opinions expressed in this email are those of the author and do not represent those of Penn Highlands Healthcare or its affiliates.. Warning: Although precautions have been taken to make sure no viruses are present in this email, the company cannot accept responsibility for any loss or damage that arise from the use of this email or attachments.
________________________________
CH Disclaimer: This electronic mail message is intended exclusively for the individual or entity to which it is addressed. This message, together with any attachment, may contain confidential and privileged information. Any views, opinions or conclusions expressed in this message are those of the individual sender and do not necessarily reflect the views of Cottage Health, its subsidiaries or affiliates. This document may also contain information covered under the Health Insurance Portability and Accountability Act (HIPAA, PL 104-191) and implementing regulations and must be protected in accordance with those provisions. Re-disclosure without patient consent or as otherwise permitted by law is prohibited. Any unauthorized review, retransmission, use, printing, copying, retention, disclosure, distribution or the taking of any action in reliance upon this information by persons or entities other than the intended recipient is strictly prohibited and may be unlawful. If you have received this message in error, please immediately advise the sender by reply email message to the sender and delete all copies of this message from your system without copying.
________________________________
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mylist.net/archives/mcoh-eh/attachments/20170901/a2f3eabc/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.jpg
Type: image/jpeg
Size: 7023 bytes
Desc: image001.jpg
URL: <https://mylist.net/archives/mcoh-eh/attachments/20170901/a2f3eabc/attachment-0002.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image002.jpg
Type: image/jpeg
Size: 3371 bytes
Desc: image002.jpg
URL: <https://mylist.net/archives/mcoh-eh/attachments/20170901/a2f3eabc/attachment-0003.jpg>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image004.png
Type: image/png
Size: 7495 bytes
Desc: image004.png
URL: <https://mylist.net/archives/mcoh-eh/attachments/20170901/a2f3eabc/attachment-0001.png>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: I - HazardousAntineoplastic Drug Questionnaire.pdf
Type: application/pdf
Size: 145553 bytes
Desc: I - HazardousAntineoplastic Drug Questionnaire.pdf
URL: <https://mylist.net/archives/mcoh-eh/attachments/20170901/a2f3eabc/attachment-0002.pdf>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: J - HazardousAntineoplastic Drug Annual Speciality Medical Evaluation .pdf
Type: application/pdf
Size: 108409 bytes
Desc: J - HazardousAntineoplastic Drug Annual Speciality Medical Evaluation .pdf
URL: <https://mylist.net/archives/mcoh-eh/attachments/20170901/a2f3eabc/attachment-0003.pdf>
More information about the MCOH-EH
mailing list